Rankings
▼
Calendar
SLDB FY 2023 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena
SLDB
Solid Biosciences Inc.
$644M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$3M
Operating Income
-$104M
Net Income
-$96M
EPS (Diluted)
$-4.83
Cash Flow
Operating Cash Flow
-$94M
Free Cash Flow
-$96M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$165M
Total Liabilities
$38M
Stockholders' Equity
$126M
Cash & Equivalents
$74M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$8M
-100.0%
Gross Profit
-$3M
$8M
-131.9%
Operating Income
-$104M
-$106M
+2.0%
Net Income
-$96M
-$86M
-11.7%
← Q4 2022
All Quarters
Q1 2023 →